Does Allogeneic HSCT Play a Role in First-Line Post-Remission Therapy for AML Patients with T(8;21) in First Complete Remission?

✍ Scribed by H.-H. Zhu; X.-H. Zhang; H. Jiang; D.-H. Liu; H. Chen; Q. Jiang; L.-P. Xu; J. Lu; W. Han; L. Bao; Y. Wang; Y.-H. Chen; X.-J. Lu; J.-Z. Wang; F.-R. Wang; Y.-Z. Qin; Y.-Y. Lai; R.-R. Liu; K.-Y. Liu; B. Jiang; X.-J. Huang

• Book ID: 116283127
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 45 KB
• Volume: 18
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2011.12.315